UBS Group »

Beam Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.1M 261k 27.21
2023-09-30 $2.9M 119k 24.05
2023-06-30 $4.1M 127k 31.93
2023-03-31 $1.6M 53k 30.62
2022-12-31 $5.4M 139k 39.11
2022-09-30 $390k 8.2k 47.77
2022-06-30 $1.5M 40k 38.69
2022-03-31 $3.8M 66k 57.29
2021-12-31 $3.1M 39k 79.75
2021-09-30 $4.2M 49k 87.00
2021-06-30 $3.7M 29k 128.69
2021-03-31 $7.1M 88k 80.04
2020-12-31 $1.8M 22k 81.65
2020-09-30 $110k 4.5k 24.66
2020-06-30 $203k 7.2k 28.06
2020-03-31 $14k 800 17.50